Long-acting reversible contraception


Barriersand facilitators to the delivery and uptake of long-acting reversible contraception: What are the views of GPs?

Theuse of long-acting reversible contraception (LARCs) remains low in Australia,despite their high efficacy.

The use of long-acting reversible contraception(LARCs) remains low in Australia, despite their high efficacy. We aimed toidentify barriers and facilitators to the uptake of LARCs in general practiceby undertaking semi-structured telephone interviews with 20 GPs from around Australia.

Our preliminary findings show that some GPs are unaware of theefficacy and suitability of LARCs. They believe that incentives would be avaluable motivator for GPs to raise and discuss LARCs during contraceptiveconsultations. GPs report not discussing LARCs with patients who expresssatisfaction with their current contraception. They believe that IUD insertionincurs increased costs of medical indemnity insurance. GPs also believepatients had negative perceptions about LARCs based on the experiences of theirpeers and are therefore reluctant to choose LARCs.

Our findings willinform the development of interventions aimed at increasing LARC uptake amongAustralian women, with potential public health benefits and reduced costs tothe health care system.

This study to bepresented at the GP17 RACGP Conference in Sydney from 26-28 October 2017 formspart of a broader research theme focused on women’s sexual and reproductivehealth being undertaken in the Department.

We welcome involvement of GPs in the community in ourwork. For further information please contact Professor Danielle Mazza at Danielle.mazza@monash.edu